"Mucormycosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection in humans and animals caused by any fungus in the order Mucorales (e.g., Absidia, Mucor, Rhizopus etc.) There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. (From Dorland, 28th ed)
Below are MeSH descriptors whose meaning is more general than "Mucormycosis".
Below are MeSH descriptors whose meaning is more specific than "Mucormycosis".
This graph shows the total number of publications written about "Mucormycosis" by people in Harvard Catalyst Profiles by year, and whether "Mucormycosis" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2011 | 3 | 0 | 3 |
2012 | 0 | 1 | 1 |
2013 | 3 | 1 | 4 |
2014 | 3 | 1 | 4 |
2015 | 3 | 1 | 4 |
2016 | 6 | 1 | 7 |
2017 | 2 | 0 | 2 |
2018 | 5 | 2 | 7 |
2019 | 2 | 1 | 3 |
2020 | 4 | 1 | 5 |
2021 | 4 | 0 | 4 |
2022 | 3 | 0 | 3 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Mucormycosis" by people in Profiles.
-
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa. Med Mycol. 2024 Jan 09; 62(1).
-
Mucorales fungi suppress nitric oxide production by macrophages. mBio. 2024 Jan 16; 15(1):e0284823.
-
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Expert Rev Anti Infect Ther. 2023 05; 21(5):535-549.
-
A Multiplex PCR and DNA-Sequencing Workflow on Serum for the Diagnosis and Species Identification for Invasive Aspergillosis and Mucormycosis. J Clin Microbiol. 2023 01 26; 61(1):e0140922.
-
Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study. Mycopathologia. 2022 Dec; 187(5-6):469-479.
-
Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review. Orbit. 2022 Dec; 41(6):670-679.
-
A Case Report of Fatal Mucormycosis in a 30-Year-Old Patient with Autoimmune Polyendocrine Syndrome Type 1. J Clin Immunol. 2022 05; 42(4):863-865.
-
Rhinocerebral Mucormycosis as a Sequelae of COVID-19 Treatment: A Case Report & Literature Review. J Oral Maxillofac Surg. 2022 02; 80(2):333-340.
-
Isavuconazole Treatment of Invasive Fungal Sinusitis: A Post Hoc Analysis of the SECURE and VITAL Trials. Clin Infect Dis. 2021 09 15; 73(6):e1380-e1383.
-
New-Onset Pediatric Diabetes Complicated By Diabetic Ketoacidosis and Invasive Rhinocerebral Mucormycosis With Internal Carotid Artery Occlusion. J Emerg Med. 2022 01; 62(1):95-100.